Psychedelic Stocks Archives - Page 37 of 61

WednesdayJan 04, 2023 11:50 am

Schools Step Up Training for Psychedelic Therapy Professionals

Psychedelic therapies are poised to revolutionize the psychiatric industry. With America’s mental health crisis getting worse by the year, researchers have been casting their attention on psychedelics for their potential mental-health benefits. Initial research into hallucinogenic drugs such as psilocybin and ketamine has revealed that they are capable of alleviating the symptoms of a variety of mental illnesses. As a result, pharmaceutical companies have been injecting millions of dollars into psychedelic research and the development of psychedelic-assisted therapies. Experts predict that the market for psychedelic drugs will grow explosively over the next decade, increasing from around $2 billion in 2020…

TuesdayJan 03, 2023 3:44 pm

Three Trends That May Shape the Psychedelics Industry Next Year

The psychedelics industry has grown significantly these past few years. However, before it can deliver on its potential, the sector will need to achieve various milestones and overcome certain challenges. Below, we look at some of the trends that may shape this burgeoning industry in 2023. Drug approvals Companies such as Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) and Compass Pathways have been conducting clinical trials on psychedelic drugs for the treatment of a range of conditions. These trials may make or break the psychedelic industry’s viability, which further highlights the huge role they can play in the…

ThursdayDec 29, 2022 12:41 pm

California Senator Refiles Measure to Legalize Psychedelics in 2023

Senator Scott Wiener of California has filed a measure to legalize the possession of a number of psychedelics. This comes after his office announced earlier this week that Wiener would be introducing the revised bill again in 2023. The revised bill will revoke state law that prohibits any mycelium or spores capable of producing mushrooms that contain psilocin or psilocybin. Psilocybin and psilocin are two of the major psychoactive components found in magic mushrooms. The ban on drug paraphernalia imposed on the substances mentioned in the state of California will also be repealed under the revised bill. During a phone…

WednesdayDec 28, 2022 11:49 am

Psychedelic Therapy May Soon Feature in Health Benefits

Every few years, new or previously forgotten discoveries shake up the very foundation of how industries operate. The development of the internet, for instance, altered society in a multitude of ways, enabling previously unknown ways of connecting and thinking and completely revolutionizing how society functions. Psychedelics are poised to transform the psychiatric industry in a similar way. Mental illness has gripped the American populace for decades now, with reports showing that mental health in America has been getting worse for quite a while now. Although pharmaceutical medications can be used to treat mental disorders, they often come with a multitude…

TuesdayDec 27, 2022 2:12 pm

Quebec Becomes First Province in Canada to Cover Psilocybin Therapy Costs

The province of Quebec recently became the first in Canada to cover expenses associated with psilocybin therapy. This comes as the use of psychedelics in mental health care gains popularity across Canada as well as neighboring countries such as the United States. Therapsil, a nonprofit healthcare advocacy focused on expanding legal, equitable and safe access to psilocybin-assisted therapy, was involved. The advocacy group confirmed that after getting permission from Health Canada, two doctors had succeeded in billing the province of Quebec for treatment using psilocybin-assisted psychotherapy, noting that the entire process had been legal. This marks a turning point in…

ThursdayDec 22, 2022 12:36 pm

Study Suggests That Psilocybin Boosts Mindfulness

Over the past couple of years, Big Pharma and investors have poured millions of dollars into psychedelic research. Initial studies have found that psychedelic drugs such as psilocybin, mescaline and ketamine may offer significant mental health benefits. When paired with physiotherapy, these hallucinogenic drugs can deliver profound benefits against conditions such as post-traumatic stress disorder, depression, and eating disorders. Studies have indicated that psychedelics deliver these benefits by causing users to have profound changes in patients' beliefs about consciousness, meaning and purpose. A recently published study sought to understand the association between serotonin receptors, mystical-like experiences, mindfulness and psilocybin. Psilocybin…

WednesdayDec 21, 2022 11:33 am

Christmas As We Know It May Be Based On Psychedelic Traditions

We’ve all heard about Santa’s reindeer flying around the world as Santa drops off presents for kids who have been nice all year. Have you ever thought about how these animals fly though? If you guessed psychedelics, you may be right. Some historians argue that Father Christmas is a psychedelic mushroom shaman, as shown by his red-and-white suit, which bears resemblance to the psychedelic fly agaric mushroom. This mushroom, scientifically known as Amanita muscaria, is bright red with white flecks. Historical evidence on indigenous psychedelic shamanism in northern Europe and Siberia even suggests that the Christmas we know today is…

TuesdayDec 20, 2022 2:00 pm

Psychedelic Drug Developers to Carry Out Clinical Trials in UK

Some psychedelic medicine developers in the United States and Canada have entered into an agreement with Clerkenwell Health in order to carry out trials on their drugs for various mental health indications in the United Kingdom. Clerkenwell Health is a clinical research organization that conducts trials for therapies for a range of mental health illnesses in London. The drug developers hope to treat mental health conditions such as major depressive disorder, social anxiety, nicotine addiction and autism spectrum disorder as well as adjustment disorder for patients with diagnoses of terminal illnesses, including cancer. Data from trials conducted in the United…

MondayDec 19, 2022 11:32 am

Three Theories Explaining Causes of Depression

Researchers have spent a significant amount of time trying to figure out the mechanisms that cause depression in an effort to develop preventative and treatment strategies for the mental condition. Over decades of intense research, three theories have emerged as the most plausible. The monoamine theory posits that the depletion of key hormones such as serotonin, norepinephrine and/or dopamine was instrumental in the development of antidepressants. This theory stated that a chemical imbalance in the brain and nervous system was to blame for the development of depression. More specifically, it said that a deficiency in monoamine transmitters was the primary…

FridayDec 16, 2022 1:01 pm

Johns Hopkins Researchers Document Different Psychedelic-Induced Belief Changes

Psychedelics have become popular in the scientific community these past few years. Long prohibited by federal law, psychedelics are now enjoying a renaissance that is predicted to cause major waves in the psychiatry industry. Initial studies have found that hallucinogenic drugs such as psilocybin, MDMA and ketamine can have significant mental health benefits, especially when they are paired with psychotherapy. Over the past couple of years, the pharmaceutical industry and investors have injected millions in funding psychedelic research with the aim of developing psychedelic-assisted therapies capable of treating debilitating mental health conditions such as depression and post-traumatic stress disorder. Researchers…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Psychedelic Stocks